Givlaari is an aminolevulinate synthase 1-directed small interfering RNA used for the treatment of adults with acute hepatic porphyria (AHP).
Recommended Dosage: The recommended dose is 2.5 mg/kg administered via subcutaneous injection once monthly. Dosing is typically based on actual body weight.
Administer givlaari injection as soon as possible following a missed dose. Resume dosing with Givlaari at monthly intervals after administration of the missed dose.
What documents are required to import GIVLAARI to India?
GIVLAARI (Givosiran Injection) can be imported by patients or government hospitals on the name of the patients only.
The following documentation required to import the product:
- Valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients Identity Proof (issued by government of India)
How does order be confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription of Doctor
- Import permit if applicable
Is GIVLAARI available in India?
GIVLAARI (givosiran injection) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input
- On availability of Givlaari in India (Ahmedabad, Mumbai, Kolkata, Hyderabad, Chennai, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
GIVLAARI can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
IPN (Indian Pharma Network) can facilitate the supply of GIVLAARI (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-9310090915 | Toll-Free No: 1800-889-1064 or write us at email@example.com for givlaari injection price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source the GIVLAARI (Cancer Treatment Medicines) from across the globe, and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Givlaari®?
Givosiran is Generic Name for the trade name drug Givlaari®.
Is Givlaari® approved by the FDA?
Yes, Givlaari (Givosiran Injection) is approved by the FDA. Date of approval: November 20, 2019.
Is Givlaari® a biologic?
Yes, Givlaari is a biologic therapy that is authorized to treat patients with acute hepatic porphyria (AHP).
What is the dosage and form of Givlaari® supplied?
Givlaari® is supplied as Injection: 189 mg/mL in a single-dose vial for subcutaneous administration.
What are the most common side effects due to Givlaari®?
Most common side effects due to Givlaari® include: nausea and injection site reactions.
How much does Givosiran cost in India?
The givosiran cost in India is reasonable and can vary. In order to procure this acute hepatic porphyria medication authentically, you can call or WhatsApp +91-9310090915 or send mail to firstname.lastname@example.org.
What are the storage conditions of Givlaari®?
Store at 2°C to 25°C (36°F to 77°F). Store this medicinal product in its original container until ready for use.
Is it safe to buy Givlaari® online in India?
Yes, You can buy Givlaari online in India legitimately from https://indianpharmanetwork.in/ if the medication has not been approved or is not available in your country.
What are the Highlights of prescribing information for Givlaari®?